ANDA 75896, held by Sun Pharmaceutical Industries. Felodipine.
As of Nov 20, 2026, ANDA 75896 (Felodipine), held by Sun Pharmaceutical Industries, was first approved by FDA on Nov 2, 2004, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 2, 2004 | Original application | Approved |
| Felodipine2.5MG · tablet, extended release;oral | Felodipine | Discontinued |
| Felodipine5MG · tablet, extended release;oral | Felodipine | Discontinued |
| Felodipine10MG · tablet, extended release;oral | Felodipine | Discontinued |
| Feb 13, 2013 | Supplement 13Labeling · Standard review | Approved | None posted |
| Feb 13, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Nov 2, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters